Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$3.85 - $10.93 $292 - $830
76 New
76 $0
Q1 2023

Apr 28, 2023

BUY
$2.79 - $6.27 $535 - $1,203
192 New
192 $1,000
Q3 2022

Nov 08, 2022

BUY
$4.09 - $6.5 $4,887 - $7,767
1,195 New
1,195 $5,000
Q4 2021

Jan 25, 2022

SELL
$6.16 - $12.07 $825 - $1,617
-134 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$7.36 - $9.87 $986 - $1,322
134 New
134 $1,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.